î
îŒ
î
Relay Therapeutics Inc
RLAY8.560USD
-0.090-1.04%
çµå€Â 12/26, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
1.48Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Relay Therapeutics Inc äŒæ¥å
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Companyâs initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Its Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Companyâs lead product candidates, such as RLY-2608. It is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including RLY-2608. RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3Kα), inhibitor in clinical development. It is the lead program in its efforts to discover and develop mutant selective inhibitors of PI3Kα.
Relay Therapeutics Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãRLAY
äŒç€ŸåRelay Therapeutics Inc
äžå Žæ¥Jul 16, 2020
æé«çµå¶è²¬ä»»è
ãCEOãPatel (Sanjiv K)
åŸæ¥å¡æ°261
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jul 16
æ¬ç€Ÿæåšå°60 Hampshire Street
éœåžCAMBRIDGE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·02139
é»è©±çªå·16173708837
ãŠã§ããµã€ãhttps://relaytx.com/
äŒæ¥ã³ãŒãRLAY
äžå Žæ¥Jul 16, 2020
æé«çµå¶è²¬ä»»è
ãCEOãPatel (Sanjiv K)
Relay Therapeutics Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Mark Murcko, Ph.D.
Dr. Mark Murcko, Ph.D.
Independent Director
Independent Director
996.95K
--
Mr. Brian R. Adams, J.D.
Mr. Brian R. Adams, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
178.96K
-10.01%
Mr. Peter (Pete) Rahmer
Mr. Peter (Pete) Rahmer
Chief Corporate Development Officer
Chief Corporate Development Officer
132.75K
-23.39%
Mr. Douglas S. (Doug) Ingram, Esq., J.D.
Mr. Douglas S. (Doug) Ingram, Esq., J.D.
Independent Director
Independent Director
25.00K
--
Dr. Donald A. Bergstrom, M.D., Ph.D.
Dr. Donald A. Bergstrom, M.D., Ph.D.
President - Research and Development
President - Research and Development
--
--
Dr. Linda A. Hill, Ph.D.
Dr. Linda A. Hill, Ph.D.
Independent Director
Independent Director
--
--
Dr. Sanjiv K. Patel, M.D.
Dr. Sanjiv K. Patel, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Thomas (Tom) Catinazzo
Mr. Thomas (Tom) Catinazzo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Sekar (Sek) Kathiresan, M.D.
Dr. Sekar (Sek) Kathiresan, M.D.
Independent Director
Independent Director
--
--
Dr. Claire Mazumdar, Ph.D.
Dr. Claire Mazumdar, Ph.D.
Independent Director
Independent Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Mark Murcko, Ph.D.
Dr. Mark Murcko, Ph.D.
Independent Director
Independent Director
996.95K
--
Mr. Brian R. Adams, J.D.
Mr. Brian R. Adams, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
178.96K
-10.01%
Mr. Peter (Pete) Rahmer
Mr. Peter (Pete) Rahmer
Chief Corporate Development Officer
Chief Corporate Development Officer
132.75K
-23.39%
Mr. Douglas S. (Doug) Ingram, Esq., J.D.
Mr. Douglas S. (Doug) Ingram, Esq., J.D.
Independent Director
Independent Director
25.00K
--
Dr. Donald A. Bergstrom, M.D., Ph.D.
Dr. Donald A. Bergstrom, M.D., Ph.D.
President - Research and Development
President - Research and Development
--
--
Dr. Linda A. Hill, Ph.D.
Dr. Linda A. Hill, Ph.D.
Independent Director
Independent Director
--
--
åçå èš³
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2023
FY2022
FY2021
FY2020
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
United States
677.00K
0.00%
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Tue, Nov 18
æŽæ°æå»: Tue, Nov 18
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
SB Investment Advisers (UK) Limited
16.10%
Commodore Capital LP
9.81%
Point72 Asset Management, L.P.
8.52%
Casdin Capital, LLC
6.54%
BlackRock Institutional Trust Company, N.A.
6.05%
ä»ã®
52.98%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
SB Investment Advisers (UK) Limited
16.10%
Commodore Capital LP
9.81%
Point72 Asset Management, L.P.
8.52%
Casdin Capital, LLC
6.54%
BlackRock Institutional Trust Company, N.A.
6.05%
ä»ã®
52.98%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Hedge Fund
36.68%
Investment Advisor
27.26%
Private Equity
16.70%
Investment Advisor/Hedge Fund
13.16%
Research Firm
2.08%
Individual Investor
1.32%
Venture Capital
0.91%
Sovereign Wealth Fund
0.48%
Family Office
0.45%
ä»ã®
0.96%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Oct 1
æŽæ°æå»: Wed, Oct 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
457
168.31M
97.11%
-38.09M
2025Q2
460
180.78M
105.44%
-7.40M
2025Q1
473
175.15M
102.43%
-21.99M
2024Q4
463
170.97M
101.10%
-14.45M
2024Q3
455
166.81M
103.61%
+17.06M
2024Q2
434
132.20M
98.83%
-25.01M
2024Q1
423
138.51M
105.71%
-7.14M
2023Q4
410
132.38M
103.96%
-10.79M
2023Q3
396
136.20M
110.68%
-5.83M
2023Q2
397
136.32M
112.15%
-5.86M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
SB Investment Advisers (UK) Limited
27.90M
16.19%
--
--
Jun 30, 2025
Commodore Capital LP
13.35M
7.74%
+3.35M
+33.50%
Jun 30, 2025
Point72 Asset Management, L.P.
13.45M
7.8%
+2.62M
+24.19%
Jun 30, 2025
Casdin Capital, LLC
11.40M
6.61%
+2.30M
+25.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.63M
6.16%
-159.25K
-1.48%
Jun 30, 2025
The Vanguard Group, Inc.
9.35M
5.42%
-2.73M
-22.57%
Jun 30, 2025
Bellevue Asset Management AG
8.23M
4.77%
+853.58K
+11.57%
Jun 30, 2025
Tang Capital Management, LLC
8.07M
4.68%
--
--
Jun 30, 2025
State Street Investment Management (US)
5.20M
3.02%
+43.60K
+0.85%
Jun 30, 2025
Nextech Invest, Ltd.
3.85M
2.23%
--
--
Jun 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Virtus LifeSci Biotech Clinical Trials ETF
1.4%
Tema Oncology ETF
0.98%
ALPS Medical Breakthroughs ETF
0.51%
State Street SPDR S&P Biotech ETF
0.33%
ProShares Ultra Nasdaq Biotechnology
0.17%
Direxion Daily S&P Biotech Bull 3X Shares
0.16%
Avantis US Small Cap Equity ETF
0.14%
Invesco Nasdaq Biotechnology ETF
0.12%
Invesco RAFI US 1500 Small-Mid ETF
0.09%
iShares Biotechnology ETF
0.08%
詳现ãèŠã
Virtus LifeSci Biotech Clinical Trials ETF
æ¯ç1.4%
Tema Oncology ETF
æ¯ç0.98%
ALPS Medical Breakthroughs ETF
æ¯ç0.51%
State Street SPDR S&P Biotech ETF
æ¯ç0.33%
ProShares Ultra Nasdaq Biotechnology
æ¯ç0.17%
Direxion Daily S&P Biotech Bull 3X Shares
æ¯ç0.16%
Avantis US Small Cap Equity ETF
æ¯ç0.14%
Invesco Nasdaq Biotechnology ETF
æ¯ç0.12%
Invesco RAFI US 1500 Small-Mid ETF
æ¯ç0.09%
iShares Biotechnology ETF
æ¯ç0.08%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
ãããã質å
Relay Therapeutics Incã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îRelay Therapeutics Incã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
SB Investment Advisers (UK) Limitedã¯27.90Mæ ªãä¿æããŠãããããã¯å šäœã®16.19%ã«çžåœããŸãã
Commodore Capital LPã¯13.35Mæ ªãä¿æããŠãããããã¯å šäœã®7.74%ã«çžåœããŸãã
Point72 Asset Management, L.P.ã¯13.45Mæ ªãä¿æããŠãããããã¯å šäœã®7.80%ã«çžåœããŸãã
Casdin Capital, LLCã¯11.40Mæ ªãä¿æããŠãããããã¯å šäœã®6.61%ã«çžåœããŸãã
BlackRock Institutional Trust Company, N.A.ã¯10.63Mæ ªãä¿æããŠãããããã¯å šäœã®6.16%ã«çžåœããŸãã
SB Investment Advisers (UK) Limitedã¯27.90Mæ ªãä¿æããŠãããããã¯å šäœã®16.19%ã«çžåœããŸãã
Commodore Capital LPã¯13.35Mæ ªãä¿æããŠãããããã¯å šäœã®7.74%ã«çžåœããŸãã
Point72 Asset Management, L.P.ã¯13.45Mæ ªãä¿æããŠãããããã¯å šäœã®7.80%ã«çžåœããŸãã
Casdin Capital, LLCã¯11.40Mæ ªãä¿æããŠãããããã¯å šäœã®6.61%ã«çžåœããŸãã
BlackRock Institutional Trust Company, N.A.ã¯10.63Mæ ªãä¿æããŠãããããã¯å šäœã®6.16%ã«çžåœããŸãã
Relay Therapeutics Incã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îRelay Therapeutics Incã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
SB Investment Advisers (UK) Limited
Commodore Capital LP
Point72 Asset Management, L.P.
SB Investment Advisers (UK) Limited
Commodore Capital LP
Point72 Asset Management, L.P.
Relay Therapeutics IncïŒRLAYïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q3æç¹ã§ãRelay Therapeutics Incã®æ ªåŒãä¿æããŠããæ©é¢ã¯457瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ168.31Mã§ãå
šäœã®97.11%ãå ããŠããŸãã2025Q2ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-8.33%å¢å ããŠããŸãã
Relay Therapeutics Incã®æ倧ã®åçæºã¯äœã§ããïŒ
îFY2025Q2ã«ãããŠã--éšéãRelay Therapeutics Incã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
